ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011